BioHealth News
BHI Reflections from the 43rd Annual J.P. Morgan Healthcare Conference
The 43rd Annual J.P. Morgan Healthcare Conference, held from January 13–16, 2025, in San Francisco, once again brought together industry leaders, investors, and innovators…
Read More
Pharmaceutical Technology: Emergent seeking to reverse fortunes and become a major overdose treatment player
Emergent BioSolutions (Gaithersburg, US) has purchased US and Canadian rights to Kloxxado, adding to its opioid overdose treatment portfolio, which includes Narcan. The growing…
Read More
TEDCO Invests in Nostopharma
COLUMBIA, Md., (January 24, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $250,000 Builder Fund investment in Nostopharma, a musculoskeletal…
Read More
Ascentage Pharma Announces Pricing of U.S. Initial Public Offering
ROCKVILLE, Md. and SUZHOU, China, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the pricing of its U.S.…
Read More
IonQ CEO on Timeline to Quantum Value
COLLEGE PARK, Md.--(BUSINESS WIRE)-- The following is a statement from Peter Chapman, Chairman and CEO of IonQ (NYSE: IONQ): Today’s classical computing hardware is limited…
Read More
On Demand Pharmaceuticals Appoints Jarrod Borkat, MBA, as Chief Strategy and Commercial Officer
Rockville, MD, United States, October 22, 2024 — On Demand Pharmaceuticals (ODP), a pioneering leader in agile distributed medicine manufacturing, is thrilled to announce the…
Read More
Linshom Medical Announces FDA Clearance of the Company’s 2nd Generation Respiratory Sensor
BALTIMORE, MD, UNITED STATES, January 21, 2025 /EINPresswire.com/ -- Linshom Medical announced today U.S. Food and Drug Administration, 510(k), clearance of the company’s two-piece, wearable respiratory…
Read More
CES2025: How “AgeTech” Is Empowering Wellbeing, Through the Eyes of BHI’s John Reinhart
CES2025 once again brought the world’s brightest minds and groundbreaking innovations to Las Vegas. With over 4,500 exhibitors and more than 141,000 attendees, the…
Read More
TEDCO Invests in NanoBioFAB
Maryland-based medical device company receives investment from Pre-Seed Builder Fund. COLUMBIA, Md., (January 20, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced…
Read More
Pioneering Pediatric Innovation: Dr. Kolaleh Eskandanian on Transforming Child Healthcare on BioTalk
[vc_row type="in_container" full_screen_row_position="middle" column_margin="default" column_direction="default" column_direction_tablet="default" column_direction_phone="default" scene_position="center" text_color="dark" text_align="left" row_border_radius="none" row_border_radius_applies="bg" overlay_strength="0.3" gradient_direction="left_to_right" shape_divider_position="bottom" bg_image_animation="none"][vc_column column_padding="no-extra-padding" column_padding_tablet="inherit" column_padding_phone="inherit" column_padding_position="all" column_element_spacing="default" background_color_opacity="1" background_hover_color_opacity="1" column_shadow="none"…
Read More
UVA Today: Biotech Accelerator To Launch in Charlottesville
By Bethanie Glover, ffu4bm@virginia.edu January 15, 2025 - The commonwealth’s biotechnology and innovation footprint is expanding, thanks to an award from the state’s GO…
Read More
TEDCO Selects AIN to Support Management and Investment of Allocated SSBCI Funding
AIN becomes the second selected VCLP to support the next generation of technology innovation COLUMBIA, Md., (January 15, 2025) — TEDCO, Maryland’s economic engine…
Read More
CvilleBioHub Enters Into A Virginia Collaboration Network And Will Launch New Biotech Accelerator In Charlottesville
GO Virginia, University of Virginia, Manning Family Foundation, and local Economic Development support the three-year project driving life sciences entrepreneurship. Charlottesville, VA (January 14, 2025) --- The…
Read More
REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases
ROCKVILLE, Md., Jan. 14, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) and Nippon Shinyaku Co., Ltd. (Nippon Shinyaku) today announced a strategic partnership for the development and commercialization…
Read More
EMBL: Researchers uncover what drives aggressive bone cancer
January 14, 2025 - Vicky Hatch - Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the…
Read More